
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
DocGo Inc (DCGO)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: DCGO (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -42.8% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 273.31M USD | Price to earnings Ratio 14.89 | 1Y Target Price 5.05 |
Price to earnings Ratio 14.89 | 1Y Target Price 5.05 | ||
Volume (30-day avg) 1067141 | Beta 1.08 | 52 Weeks Range 2.51 - 5.67 | Updated Date 04/2/2025 |
52 Weeks Range 2.51 - 5.67 | Updated Date 04/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.18 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.24% | Operating Margin (TTM) -6.19% |
Management Effectiveness
Return on Assets (TTM) 3.79% | Return on Equity (TTM) 4.31% |
Valuation
Trailing PE 14.89 | Forward PE 60.24 | Enterprise Value 241258504 | Price to Sales(TTM) 0.44 |
Enterprise Value 241258504 | Price to Sales(TTM) 0.44 | ||
Enterprise Value to Revenue 0.39 | Enterprise Value to EBITDA 5.29 | Shares Outstanding 101983000 | Shares Floating 86183413 |
Shares Outstanding 101983000 | Shares Floating 86183413 | ||
Percent Insiders 8.83 | Percent Institutions 52.34 |
Analyst Ratings
Rating 4.86 | Target Price 6.22 | Buy 1 | Strong Buy 6 |
Buy 1 | Strong Buy 6 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
DocGo Inc
Company Overview
History and Background
DocGo Inc. was founded in 2015. Initially focused on mobile health services, it expanded its offerings to include last-mile mobile health and remote patient monitoring. The company went public via a SPAC merger in November 2021.
Core Business Areas
- Mobile Health Services: Provides on-site medical care, including testing, vaccinations, and urgent care, at patients' homes, workplaces, and events. It is the primary revenue driver.
- Remote Patient Monitoring: Offers remote monitoring solutions for patients with chronic conditions, enabling healthcare providers to track vital signs and manage treatment plans remotely.
- Transportation Services: Ambulance and medical transportation service.
Leadership and Structure
Anthony Capone serves as CEO. The company has a board of directors and operates with a functional organizational structure, grouping employees by specialty.
Top Products and Market Share
Key Offerings
- Mobile Health Services: On-demand medical services delivered directly to patients. Market share data is not readily available as the market is fragmented. Competitors include dispatchhealth and traditional urgent care centers.
- Remote Patient Monitoring: Utilizes technology to monitor patients outside of traditional healthcare settings. Market share data for DocGo specifically is limited. Key competitors include Teladoc and Omron Healthcare.
- Ambulance Services: Ambulance services provided by DocGo under contracts. Key competitors include Acadian Ambulance Service, and Falck.
Market Dynamics
Industry Overview
The healthcare services industry is experiencing growth due to increasing demand for convenient and accessible healthcare options, driven by factors such as aging populations and the rise of chronic diseases.
Positioning
DocGo is positioned as an innovator in mobile health, offering a convenient alternative to traditional healthcare settings. Its competitive advantages lie in its technology platform, rapid response times, and cost-effectiveness.
Total Addressable Market (TAM)
The TAM for mobile health and remote patient monitoring is estimated to be in the billions of dollars. DocGo is positioned to capture a significant share through its expanding service offerings and geographic reach.
Upturn SWOT Analysis
Strengths
- Innovative technology platform
- Rapid response times
- Cost-effectiveness
- Experienced management team
- Established contracts with government and private organizations
Weaknesses
- Dependence on key contracts
- Geographic concentration
- Potential regulatory hurdles
- High marketing and sales expenses
Opportunities
- Expanding service offerings
- Geographic expansion
- Strategic acquisitions
- Partnerships with healthcare providers
- Increased adoption of telehealth
Threats
- Intense competition
- Changes in healthcare regulations
- Economic downturn
- Data security breaches
- Negative publicity
Competitors and Market Share
Key Competitors
- AMN Healthcare Services (AMN)
- Teladoc Health (TDOC)
- Global Medical Response (GMR)
Competitive Landscape
DocGo's technology and mobile service model provides a competitive advantage over traditional healthcare providers. However, larger players have broader service offerings and established market presence.
Major Acquisitions
Acquired Company Name
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: To expand its market presence and service offerings in remote patient monitoring.
Growth Trajectory and Initiatives
Historical Growth: DocGo has experienced rapid revenue growth in recent years, driven by increased demand for its mobile health services.
Future Projections: Analyst estimates project continued revenue growth for DocGo, driven by expanding service offerings and geographic reach.
Recent Initiatives: Recent initiatives include expanding into new markets, launching new service lines, and forming strategic partnerships.
Summary
DocGo shows promise with its innovative mobile health approach and revenue growth. Key contracts and managing expenses require careful attention. Balancing innovation and competitive pressures will influence its long-term success. While past performance has shown variable net income and a new acquisition shows growth potential, the company remains a good, yet volatile investment.
Similar Companies

AMN

AMN Healthcare Services Inc



AMN

AMN Healthcare Services Inc

TDOC

Teladoc Inc



TDOC

Teladoc Inc
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Market share data is based on estimates and may not be precise. Past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About DocGo Inc
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2021-11-05 | CEO & Director Mr. Lee Bienstock | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 3404 | Website https://www.docgo.com |
Full time employees 3404 | Website https://www.docgo.com |
DocGo Inc. provides mobile health and medical transportation services in the United States and the United Kingdom. The company offers transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also provides mobile health services through its platform that are performed at home, offices, and other locations; event services, including on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was incorporated in 2015 and is headquartered in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.